Goodwin Procter LLP advised Ikena Oncology on the deal. Ikena Oncology announced the closing of its $120 million oversubscribed Series B. The financing round was led…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
